KineMed sets IPO range

Biomarker discovery company KineMed Inc. (Emeryville, Calif.) amended its IPO on NASDAQ and now plans to sell 4.5 million shares at $6.50-$7.50. At the $7 midpoint, the company would raise $31.5 milli...